ClinicalTrials.Veeva

Menu

Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches

P

Psychiatric University Hospital, Zurich

Status and phase

Unknown
Phase 4

Conditions

Heroin Addiction

Treatments

Drug: Buprenorphine patch and sublingual tablets

Study type

Interventional

Funder types

Other

Identifiers

NCT00750217
E-54/2007

Details and patient eligibility

About

Buprenorphine is an important alternative to methadone in the maintenance treatment of heroin addiction. Transfer from methadone to buprenorphine requires a reduction of daily methadone dosage below 30 mg to avoid withdrawal after the first buprenorphine intake. The study hypothesis states that the transfer from a daily methadone dosage between 60 mg and 100 mg to buprenorphine can be carried out without withdrawal using buprenorphine patches (35 micro grams per hour) within 12 to 48 hours after last methadone intake.

Enrollment

10 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 60 years
  • Methadone maintenance treatment for at least 3 months preceding the study
  • Daily methadone dosage between 60mg amd 100mg
  • Sufficient knowledge of German language
  • Ability to give informed consent

Exclusion criteria

  • Daily methadone dosage below 60mg amd over 100mg
  • Prescribed use of benzodiazepines over 30 mg equivalent to diazepam
  • Misuse or dependence of alcohol and/or GHB/GBL
  • Pregnant or breast-feeding women
  • Known intolerance of buprenorphine
  • Somatic diseases interfering with the study plan

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems